Product Images Gabapentin

This appears to be a chart or table showing the mean pain score during a 4-week dose titration period and a subsequent 4-week fixed dose period. The two groups being compared are a placebo group and a group taking gabapentin at a dose of 3600 mg/day. The baseline is also noted.*

This appears to be a chart or graph related to a study on different dosages of Gabapentin for pain management. The chart shows the mean pain score at baseline and over several weeks for four groups: a placebo group, a group taking 1800mg/day of Gabapentin, a group taking 2400mg/day of Gabapentin, and a group undergoing a dose titration period. Beyond that, the text provides no additional information.*

The text represents a chart or table showing the proportion of responders in controlled PHN studies at endpoint. The chart shows percentage scores ranging from 10% to 100% in increments of 10%. The table provides additional data for each study, including study number, percentage of responders (ranging from 12% to 29%), and the names of different treatments (GBP 3600, PBO, GEBP 1800, and GBP 2400). There is a reference to "#p<00l < 0,001," indicating statistical significance, but it is not clear what this refers to without further context.*

The text could possibly be part of a medication label or prescription. It indicates that "Gabapentin 410mg" is available in capsule form and the quantity is "90" capsules. It also mentions a comparison, but the details are not clear. There is a reference number "90GAR4001221" at the end.*